Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 30, 2017

DrugPatentWatch Database Preview

Levalbuterol hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for levalbuterol hydrochloride and what is the scope of levalbuterol hydrochloride patent protection?

Levalbuterol hydrochloride
is the generic ingredient in two branded drugs marketed by Mylan Speciality Lp, Aurobindo Pharma Ltd, Oak Pharms Inc, Ritedose Corp, Impax Labs Inc, Cipla Ltd, Teva Parenteral, and Teva Pharms Usa, and is included in ten NDAs. There are two patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for levalbuterol hydrochloride. Fifteen suppliers are listed for this compound.

Summary for Generic Name: levalbuterol hydrochloride

Drug Master File Entries: see list9
Suppliers / Packagers: see list15
Bulk Api Vendors: see list30
Clinical Trials: see list1,005
Patent Applications: see list898
Therapeutic Class:Respiratory Tract Agents
Drug Prices:see low prices
DailyMed Link:levalbuterol hydrochloride at DailyMed

Pharmacology for Ingredient: levalbuterol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ritedose Corp
levalbuterol hydrochloride
SOLUTION;INHALATION203653-003Mar 22, 2016ANRXNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
levalbuterol hydrochloride
SOLUTION;INHALATION207628-001Jan 31, 2017ANRXNoNo► Subscribe► Subscribe
Mylan Speciality Lp
levalbuterol hydrochloride
SOLUTION;INHALATION078309-001Mar 20, 2009ANRXNoNo► Subscribe► Subscribe
Oak Pharms Inc
levalbuterol hydrochloride
SOLUTION;INHALATION020837-004Jul 18, 2003ANRXYesYes6,451,289► SubscribeY ► Subscribe
Aurobindo Pharma Ltd
levalbuterol hydrochloride
SOLUTION;INHALATION207625-003Dec 30, 2016ANRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus